For context, Roux-en-Y gastric bypass surgery weakens this circuit by approximately four-fold, which partly explains why surgical outcomes often exceed pharmaceutical ones in total weight lost
Inward relocation of exogenous phosphatidylserine triggered by IGF-1 in non-apoptotic C2C12 cells is concentration dependent
Psychological and quality of life changes in patients using GLP-1 analogues
Compared to L-arginine, an advantage to supplementation with L-citrulline is that intestinal catabolism of L-citrulline is limited since it is not metabolized by arginases, and the activity of arginosuccinate synthase is low in enterocytes [2]
What excites me most is the research into oral versions of these medications, which could make treatment more convenient and potentially more affordable
1 Introduction The advent of incretin-based therapies, including glucagon-like peptide-1 receptor agonists (GLP-1RAs) and their combinations, as pharmacological treatments for obesity and type 2 diabetes, has sparked intense debate about their role relative to traditional lifestyle interventions such as exercise and dietary modification
